Non-alcoholic steatohepatitis is independently associated with a history of gestational diabetes mellitus

被引:4
作者
Boustany, Antoine [1 ,4 ]
Onwuzo, Somtochukwu [1 ]
Zeid, Hadi Khaled Abou [3 ]
Almomani, Ashraf [1 ]
Kumar, Prabhat [1 ]
Hitawala, Asif [1 ]
Asaad, Imad [2 ]
机构
[1] Cleveland Clin Fdn, Dept Internal Med, Cleveland, OH USA
[2] Cleveland Clin Fdn, Digest Dis & Surg Inst, Cleveland, OH USA
[3] Univ Balamand, Fac Med & Med Sci, Balamand, Lebanon
[4] Cleveland Clin Fdn, Dept Internal Med, 9500 Euclide Ave, Cleveland, OH 44195 USA
关键词
Gestational diabetes mellitus; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Type 2 diabetes mellitus;
D O I
10.1111/jgh.16163
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and AimA recent study has demonstrated that women with gestational diabetes mellitus (GDM) are more likely to develop non-alcoholic fatty liver disease than those without GDM. In contrary to non-alcoholic fatty liver, the association of GDM with non-alcoholic steatohepatitis (NASH) has still not been well established in the current literature. Therefore, we aim to evaluate the association of a history of GDM and the development of NASH throughout their lives independently of type 2 diabetes mellitus (T2DM). MethodsA validated research database of more than 360 hospitals was utilized to construct this study. Adult females included were divided into two groups: those with NASH (case) and individuals without NASH (control). Regression analysis was performed to account for potential cofounders. ResultsThere were 70 632 640 individuals above the age of 18 years screened in the database. In patients with a history of GDM, NASH was most prevalent in middle age people compared with NASH alone, which was more prevalent in people aged 65 years and above. Compared with those without, patients with NASH tend to be Caucasian (odds ratio [OR]: 2.13), obese (OR: 4.83), have a history of GDM (OR: 1.23), diagnosed with hyperlipidemia (OR: 2.59), T2DM (OR: 4.52), metabolic syndrome (OR: 3.07), polycystic ovaries disease (OR: 1.72), and hypothyroidism (OR: 1.59). ConclusionWe demonstrated for the first time an increased odd of developing NASH in women who have had a diagnosis of gestational diabetes mellitus throughout their lives independently of any other factors that could interfere with the results.
引用
收藏
页码:984 / 988
页数:5
相关论文
共 28 条
  • [1] Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study
    Adejumo, Adeyinka Charles
    Alliu, Samson
    Ajayi, Tokunbo Opeyemi
    Adejumo, Kelechi Lauretta
    Adegbale, Oluwole Muyiwa
    Onyeakusi, Nnaemeka Egbuna
    Akinjero, Akintunde Micheal
    Durojaiye, Modupeoluwa
    Bukong, Terence Ndonyi
    [J]. PLOS ONE, 2017, 12 (04):
  • [2] Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease
    Ajmera, Veeral H.
    Gunderson, Erica P.
    VanWagner, Lisa B.
    Lewis, Cora E.
    Carr, John J.
    Terrault, Norah A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (05) : 658 - 664
  • [3] Epidemiology of neuroendocrine tumors of the appendix in the USA: a population-based national study (2014-2019)
    Alkhayyat, Motasem
    Abou Saleh, Mohannad
    Coronado, Wendy
    Abureesh, Mohammad
    Zmaili, Mohammad
    Qapaja, Thabet
    Almomani, Ashraf
    Khoudari, George
    Mansoor, Emad
    Cooper, Gregory
    [J]. ANNALS OF GASTROENTEROLOGY, 2021, 34 (05): : 713 - 720
  • [4] Epidemiology and risk of psychiatric disorders among patients with celiac disease: A population-based national study
    Alkhayyat, Motasem
    Qapaja, Thabet
    Aggarwal, Manik
    Almomani, Ashraf
    Abureesh, Mohammad
    Al-otoom, Omaymah
    Zmaili, Mohammad
    Mansoor, Emad
    Abou Saleh, Mohannad
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (08) : 2165 - 2170
  • [5] Prevalence of hypothyroidism and effect of thyroid hormone replacement therapy in patients with non-alcoholic fatty liver disease: A population-based study
    Almomani, Ashraf
    Hitawala, Asif Ali
    Kumar, Prabhat
    Alqaisi, Sura
    Alshaikh, Dana
    Alkhayyat, Motasem
    Asaad, Imad
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (03) : 551 - 558
  • [6] BOUSTANY A, 2023, HELICOBACTER, V36, P1, DOI DOI 10.20524/AOG.2023.0783
  • [7] Boustany A., 2022, J OPHTALMOL OPEN ACC, P6, DOI [10.17303/jooa.2022.6.105, DOI 10.17303/JOOA.2022.6.105]
  • [8] The prevalence of gestational diabetes mellitus in women diagnosed with non-alcoholic fatty liver disease during pregnancy: A systematic review and meta-analysis
    Chai, Thora Ying Li
    Rajaratnam, Romesh Mark
    Deng, Difei
    George, Jacob
    Pasupathy, Dharmintra
    Cheung, Ngai Wah
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (09)
  • [9] Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus
    Ferguson, Daniel
    Finck, Brian N.
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2021, 17 (08) : 484 - 495
  • [10] Increased prevalence of non-alcoholic fatty liver disease in European women with a history of gestational diabetes
    Forbes, S.
    Taylor-Robinson, S. D.
    Patel, N.
    Allan, P.
    Walker, B. R.
    Johnston, D. G.
    [J]. DIABETOLOGIA, 2011, 54 (03) : 641 - 647